US$ 26.24
are glp-1 receptor agonists approved for type 1 diabetes fda Indications GLP-1/GIP RA Summary Sheet and Beyond! Trends in the Development of
Description
New therapies for obesity

Since most studies focused on liraglutide and semaglutide, the outcomes are most relevant to these drugs, even though the pooled analysis considered all data from the GLP-1 RA class

Full details of the replication analysis methodology is provided in Supplementary Information

Wegovy is made by Novo Nordisk and was approved by the FDA in 2021

doi: 10.1056/NEJMoa1603827 10 GoldenbergRMSteenO

"There are 34 hormones and neurotransmitters in the brain that are linked to eating, satiety, hunger and craving